Oncotelic Therapeutics (OTLC) Invested Capital (2019 - 2026)
Oncotelic Therapeutics (OTLC) reported Invested Capital of $276.6 million for Q2 2026, compared with $20.94 million a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Invested Capital (2019 - 2026) Analysis & Trends
For FY2025, Oncotelic Therapeutics posted Invested Capital of $287.26 million.
- Invested Capital has a five-year compound annual growth rate of 79.5% (FY2020 to FY2025).
- By year, Invested Capital came in at $20.57 million in FY2024 (+4.5%), $19.68 million in FY2023 (-51.5%), $40.54 million in FY2022 (+98.8%) and $20.39 million in FY2021 (+32.2%).
- Five-year quarterly Invested Capital spans a low of $12.51 million in Q3 2021 and a high of $287.26 million in Q4 2025.
- Year over year, Invested Capital gained in two of the last five quarters, with an average decline of 0.9%.
- The high point for year-over-year Invested Capital in five years was Q3 2022 (growth of 165.9%); the low point was Q4 2023 (a decline of 51.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 51.53 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 82.72 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 148.69 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | 276.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 276.60 Mn |
| Dec 31, 2025 | 287.26 Mn |
| Sep 30, 2025 | 22.92 Mn |
| Jun 30, 2025 | 20.94 Mn |
| Mar 31, 2025 | 20.47 Mn |
| Dec 31, 2024 | 20.95 Mn |
| Sep 30, 2024 | 18.77 Mn |
| Jun 30, 2024 | 21.88 Mn |
| Mar 31, 2024 | 21.93 Mn |
| Dec 31, 2023 | 20.04 Mn |
| Sep 30, 2023 | 23.57 Mn |
| Jun 30, 2023 | 24.06 Mn |
| Mar 31, 2023 | 18.80 Mn |
| Dec 31, 2022 | 40.89 Mn |
| Sep 30, 2022 | 33.28 Mn |
| Jun 30, 2022 | 33.23 Mn |
| Mar 31, 2022 | 15.25 Mn |
| Dec 31, 2021 | 22.06 Mn |
| Sep 30, 2021 | 14.55 Mn |
| Jun 30, 2021 | 15.34 Mn |
API Access
Oncotelic Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();